United States · FDA National Drug Code directory
Lamivudine and Zidovudine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 31722-739_4cd27be5-81ed-ccb6-e063-6294a90a1798
- Product NDC
- 31722-739
- Form
- TABLET, FILM COATED
- Composition / generic term
- Lamivudine and Zidovudine
- Labeler
- Camber Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20140206
- Source listing expiry
- 20271231
Source-listed ingredients
- LAMIVUDINE — 150 mg/1
- ZIDOVUDINE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET, FILM COATED in 1 BOTTLE (31722-739-05) · 31722-739-05
- 100 TABLET, FILM COATED in 1 BLISTER PACK (31722-739-31) · 31722-739-31
- 60 TABLET, FILM COATED in 1 BOTTLE (31722-739-60) · 31722-739-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →